Periodic Reporting for period 3 - ProDAP (Protein Dynamics in Antiviral Processes)
Reporting period: 2022-04-01 to 2023-09-30
ProDAP uses proteomics and transcriptomis to identify virus interacting proteins, proteins that change their interaction profile upon virus infection and gene and proteome signatures that are regulated by these interactions. We established essential tools to study virus-host interactions and protocols that allow us to monitor the synthesis and degradation of proteins. Protein interactons and turnover are indications for involvment of the identified proteins in antiviral processes. Besides systematic analysis of the host protein interactions and turnover we apply screens to functionally classify the identified proteins.
We used the established tools to monitor the interactions and effects of SARS-CoV-2 and SARS-CoV interactions (Stulakov et al., Nature, 2021) and could thereby identify functionally relevant interactions and cellular processes that may contribute to antiviral processes. Moreover, we established technology that leverages the identified virus-host interaction data to identify drugs, which may be used for antiviral treatments.
The protocols and scientific insights of ProDAP can be expanded to a wide variety of different viruses with clinicial and socioeconomic importance. Prospectively our work will aid intelligent design of antiviral treatments based on knowledge of the given pathogen.